Self-reported history of hypercholesterolaemia and gallstones and the risk of prostate cancer.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Annals of Oncology

• Publication date

  2006-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/ANNONC/MDL080PMID 16611646
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prostate cancer epidemiology.

  2006cited by this paper
• Diabetes mellitus and the risk of prostate cancer in Italy.

  2005cited by this paper
• The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: a preliminary report.

  2005cited by this paper
• Statins and prostate cancer risk: a case-control study.

  2005cited by this paper
• Diabetes and risk of prostate cancer in a prospective cohort of US men.

  2005cited by this paper
• Family history of cancer and the risk of prostate cancer and benign prostatic hyperplasia

  2005cited by this paper
• Obesity before age 30 years and risk of advanced prostate cancer.

  2005cited by this paper
• Heart healthy equals prostate healthy equals statins: the next cancer chemoprevention trial. Part I

  2005cited by this paper
• Heart healthy equals prostate healthy equals statins: the next cancer chemoprevention trial. Part II

  2005cited by this paper
• Prostate cancer and body size at different ages: an Italian multicentre case–control study

  2004cited by this paper
• Statin use and cancer risk in the General Practice Research Database

  2004cited by this paper
• Cholesterol and prostate cancer

  2004cited by this paper
• Prostate cancer and coronary heart disease: correlation or coincidence?

  2004cited by this paper
• History of diabetes mellitus and risk of prostate cancer in physicians.

  2004cited by this paper
• Prostate cancer epidemiology.

  2003cited by this paper
• Reduced risk of prostate cancer among patients with diabetes mellitus

  2002cited by this paper
• Statin Use and the Risk of Breast and Prostate Cancer

  2002cited by this paper
• Tea and prostate cancer.

  2001cited by this paper
• Reliability of data on medical conditions, menstrual and reproductive history provided by hospital controls.

  2001cited by this paper
• International trends and patterns of prostate cancer incidence and mortality

  2000cited by this paper
• Positive association between resting pulse and cancer incidence in current and former smokers.

  1999cited by this paper
• Diet, nutrition, and prostate cancer.

  1998cited by this paper
• Diet, nutrition and prostate cancer

  1997cited by this paper
• Blood pressure and heart rate: no evidence for a positive association with prostate cancer.

  1997cited by this paper
• Heart rate and prostate cancer mortality: results of a prospective analysis.

  1995cited by this paper
• Reliability of personal interview data in a hospital-based case-control study.

  1990cited by this paper
• Heart disease risk factors, diabetes, and prostatic cancer in an adult community.

  1989cited by this paper
• Case-control studies using other diseases as controls: problems of excluding exposure-related diseases.

  1988cited by this paper

• Kidney and gallbladder stones and the risk of prostate cancer: Results from the EPICAP study

  2025cites this paper
• Dietary saturated fatty acids and prostate cancer: insights into NF-κB pathway and lipid metabolism mechanisms

  2025cites this paper
• Pan-cancer analysis reveals the potential role of DHCR24 in bladder cancer via interactions with HRAS to facilitate cholesterol synthesis

  2025cites this paper
• Ceramide As A Potential Tumor Marker For Diagnosis Of Prostate Cancer And Its Association With Lipid Profile

  2024cites this paper
• Gallstones, cholecystectomy, and cancer risk: an observational and Mendelian randomization study

  2024cites this paper
• Cholelithiasis increased prostate cancer risk: evidence from a case–control study and a meta-analysis

  2022cites this paper
• Inhibition of Scavenger Receptor Class B Type 1 (SR-B1) Expression and Activity as a Potential Novel Target to Disrupt Cholesterol Availability in Castration-Resistant Prostate Cancer

  2021cites this paper
• PCSK9 Axis-Targeting Pseurotin A as a Novel Prostate Cancer Recurrence Suppressor Lead.

  2021cites this paper
• Cholesterol and saturated fatty acids synergistically promote the malignant progression of prostate cancer

  2021cites this paper
• Association of Cholecystectomy with the Risk of Prostate Cancer in Patients with Gallstones

  2020cites this paper
• Cholesterol Induces Epithelial-to-Mesenchymal Transition of Prostate Cancer Cells by Suppressing Degradation of EGFR through APMAP.

  2019cites this paper
• Serum Li�id �ro�les and Cancer Risk in the Conte�t of Obesity: FourMeta-Analyses

  2018cites this paper
• Dietary oleic acid regulates hepatic lipogenesis through a liver X receptor-dependent signaling

  2017cites this paper
• 27-hydroxycholesterol: A novel player in molecular carcinogenesis of breast and prostate cancer.

  2017cites this paper
• BMI and serum lipid parameters predict increasing risk and aggressive prostate cancer in Chinese people

  2017cites this paper
• Biologic and epidemiologic evidence assessing if statins prevent prostate cancer.

  2017cites this paper
• Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging

  2016cites this paper
• Mechanistic Study of Inhibitory Effects of Atorvastatin and Docetaxel in Combination on Prostate Cancer.

  2016cites this paper
• Hypercholesterolemia Is Associated with a Shorter Time to Castration-Resistant Prostate Cancer in Patients Who Have Undergone Androgen Deprivation Therapy

  2016cites this paper
• Association between gallbladder stone disease and prostate cancer: A nationwide population-based study

  2016cites this paper
• Cholesterol and prostate cancer risk: a long-term prospective cohort study

  2016cites this paper
• A review of clinical effects associated with metabolic syndrome and exercise in prostate cancer patients

  2016cites this paper
• Anti‐Proliferation Effects of Garlic (Allium sativum L.) on the Progression of Benign Prostatic Hyperplasia

  2016cites this paper
• Meta-analysis of the association between the HNF1B rs4430796 (A>G) polymorphism and risk of prostate cancer based on case-control studies.

  2015cites this paper
• The HDL receptor SR-BI is associated with human prostate cancer progression and plays a possible role in establishing androgen independence

  2015cites this paper
• Cholesterol Levels in Blood and the Risk of Prostate Cancer: A Meta-analysis of 14 Prospective Studies

  2015cites this paper
• Role of Serum Cholesterol and Statin Use in the Risk of Prostate Cancer Detection and Tumor Aggressiveness

  2014cites this paper
• Oxisteróis e cancro: o papel do liver x receptor

  2014cites this paper
• Serum lipid profiles: novel biomarkers predicting advanced prostate cancer in patients receiving radical prostatectomy

  2014cites this paper
• Rôle du Liver X Receptor dans la régulation transcriptionnelle de la lipogenèse

  2013cites this paper
• Cholesterol accumulation in prostate cancer: a classic observation from a modern perspective.

  2013cites this paper
• Récepteur nucléaire LXR et cancer du sein : coopération avec les macrophages : études in vitro sur les modèles MCF-7 et THP-1

  2013cites this paper
• Serum Lipid Profiles and Cancer Risk in the Context of Obesity: Four Meta-Analyses

  2013cites this paper
• Metabolic syndrome as a peculiar target for management of prostate cancer patients.

  2013cites this paper
• Selective liver X receptor modulators (SLiMs): what use in human health?

  2012cites this paper
• Ambiguity of Plasma Cholesterol Levels as a Biomarker of Prostate Cancer

  2012cites this paper
• Cholesterol and the risk of grade-specific prostate cancer incidence: evidence from two large prospective cohort studies with up to 37 years' follow up

  2012cites this paper
• History of cholelithiasis and cancer risk in a network of case-control studies.

  2012cites this paper
• Impact d'une invalidation de LXRα sur la physiologie prostatique : un dialogue avec la signalisation androgénique

  2011influential citation
• Presence of the metabolic syndrome is associated with shorter time to castration-resistant prostate cancer.

  2011cites this paper
• Blood lipid levels and prostate cancer risk; a cohort study

  2011cites this paper
• The Immunologic Outcome of Enhanced Function of Mouse Liver Lymphocytes and Kupffer Cells by High-Fat and High-Cholesterol Diet

  2011cites this paper
• Prostate cancer risk in the Swedish AMORIS study

  2011cites this paper
• Serum total and HDL cholesterol and risk of prostate cancer

  2011cites this paper
• Liver X receptors, lipids and their reproductive secrets in the male.

  2011cites this paper
• History of cholelithiasis and the risk of prostate cancer: The Ohsaki Cohort Study

  2011cites this paper
• Low-density lipoprotein cholesterol suppresses apoptosis in human multiple myeloma cells

  2011cites this paper
• Chinese Red Yeast Rice Inhibition of Prostate Tumor Growth in SCID Mice

  2011cites this paper
• The metabolic syndrome and risk of prostate cancer in Italy.

  2011cites this paper
• Implications of body mass index in Japanese patients with prostate cancer who had undergone radical prostatectomy.

  2010cites this paper
• Understanding prostate cancer and PSA testing

  2010cites this paper
• Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells

  2010cites this paper
• Metabolic Change after Androgen Deprivation Therapy in Korean Men with Prostate Cancer

  2010cites this paper
• Dietary fat and early-onset prostate cancer risk

  2010cites this paper
• High cholesterol levels are associated with reduced prostate cancer mortality rates during periods of high but not low statin use in the United States.

  2009cites this paper
• Risk factors for prostate cancer in Universiti Kebangsaan Malaysia Medical Centre: a case-control study.

  2009cites this paper
• A Class of Semiparametric Mixture Cure Survival Models With Dependent Censoring

  2009cites this paper
• Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort

  2009cites this paper
• Mechanisms of Chinese Red Yeast Rice Inhibition of Prostate Cancer Growth

  2009cites this paper
• PERLECAN regulation of SONIC HEDGEHOG signaling in advanced prostate cancer: From Drosophila to humans

  2008cites this paper
• The Effect of the Serum Cholesterol Level on the Clinicopathologic Characteristics of Prostate Cancer

  2008cites this paper
• New developments in medulloblastoma treatment: the potential of a cyclopamine–lovastatin combination

  2008cites this paper
• The lipid raft-anchored adaptor protein Cbp controls the oncogenic potential of c-Src.

  2008cites this paper
• Statins and prostate cancer prevention: where we are now, and future directions

  2008cites this paper
• Macronutrients, fatty acids and cholesterol intake and endometrial cancer.

  2008cites this paper
• Update on the diagnosis and management of prostate cancer.

  2008cites this paper
• Hypercholesterolemia and prostate cancer: a hospital-based case–control study

  2008cites this paper
• Cholesterol-Lowering Drugs and Prostate Cancer Risk: A Population-based Case-Control Study

  2007cites this paper
• The impact of modifiable risk factors on mortality from prostate cancer in populations of the Asia-Pacific region.

  2007cites this paper
• Transit of hormonal and EGF receptor-dependent signals through cholesterol-rich membranes.

  2007cites this paper
• CHOLESTEROL, STATINS AND CANCER

  2007cites this paper
• Dietary fat’gene interactions in cancer

  2007cites this paper
• Onion and garlic intake and the odds of benign prostatic hyperplasia.

  2007cites this paper
• TITLE: Inhibition of Fatty Acid Synthase in Prostate Cancer by Olristat, a Novel Therapeutic PRINCIPAL INVESTIGATOR:

  2006cites this paper
• The role of cholesterol in prostate cancer

  2006cites this paper
• Tumorigenesis and Neoplastic Progression Ezetimibe Is an Inhibitor of Tumor Angiogenesis

  year unknowncites this paper